IUPHAR themed review: Opioid efficacy, bias, and selectivity

Keyphrases

• μ-opioid Receptor 100%
• IUPHAR 100%
• Opioid Efficacy 100%
• Kappa Opioid Receptor 60%
• Opioids 40%
• Recent Advances 20%
• Acute Pain 20%
• Analgesic 20%
• Opioid Receptor Activation 20%
• Receptor Activation 20%
• Sedation 20%
• Antidepressants 20%
• G Protein 20%
• Subtype Selectivity 20%
• Respiratory Depression 20%
• Chronic Pain 20%
• Opioid Drugs 20%
• Opioid Receptors 20%
• High Demand 20%
• Opioid Analgesics 20%
• Constipation 20%
• Dysphoria 20%
• Euphoria 20%
• Arrestin 20%
• μ Receptor 20%
• Treatment Line 20%
• Protein Pathway 20%
• Overdose Risk 20%
• Biased Agonism 20%
• Orthosteric Site 20%
• GABA Analogues 20%

Medicine and Dentistry

• μ-Opioid Receptor 100%
• κ-Opioid Receptor 50%
• Kappa Opiate Receptor 50%
• Side Effect 33%
• Receptor 16%
• Pain 16%
• Receptor Family 16%
• Intoxication 16%
• Guanine Nucleotide Binding Protein 16%
• Respiration Depression 16%
• Chronic Pain 16%
• Constipation 16%
• Retina S Antigen 16%
• Dysphoria 16%
• Selective Serotonin Reuptake Inhibitor 16%
• Gamma-Aminobutyric Acid 16%
• Narcotic Analgesic Agent 16%
• Euphoria 16%
• Opioid Receptor 16%
• Antidepressant 16%
• Analgesic 16%

Pharmacology, Toxicology and Pharmaceutical Science

• μ-Opioid Receptor 100%
• Kappa Opiate Receptor 50%
• Side Effect 33%
• Receptor 16%
• 4 Aminobutyric Acid 16%
• Analgesic Agent 16%
• Toxic Injury 16%
• Antidepressant 16%
• Guanine Nucleotide Binding Protein 16%
• Chronic Pain 16%
• Pain 16%
• Opiate Receptor 16%
• Respiration Depression 16%
• Constipation 16%
• Dysphoria 16%
• Retina S Antigen 16%
• Selective Serotonin Reuptake Inhibitor 16%
• Narcotic Analgesic Agent 16%